Goyette MA, Graser C, Seehawer M, Patmanidis A, Rojas Jimenez E, Kamat A, Yan P, Fassl A, Foidart P, Li Z, James A, Sflomos G, Brisken C, Sicinski P, Michor F, Polyak K.2026.HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies.Cancer discovery.16(8):1691-1710.Pubmed: 41925564DOI:10.1158/2159-8290.CD-25-1459
Goyette MA, Graser C, Seehawer M, Patmanidis A, Rojas Jimenez E, Kamat A, Yan P, Fassl A, Foidart P, Li Z, James A, Sflomos G, Brisken C, Sicinski P, Michor F, Polyak K.2026.HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies.Cancer discovery.16(8):1691-1710.Pubmed: 41925564DOI:10.1158/2159-8290.CD-25-1459
Franziska Michor uses the tools of theoretical evolutionary biology, applied mathematics, statistics, and computational biology to address important questions in cancer research.
